COM:ATARABIO
Atara Biotherapeutics Inc
- Stock
Last Close
10.61
22/11 21:00
Market Cap
66.06M
Beta: -
Volume Today
65.66K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 793K - | 5.65M 611.98% | ||||||||||
average payables | 363.50K - | 523K 43.88% | 942.50K 80.21% | 2.11M 124.03% | 8.74M 314.14% | 9.21M 5.38% | 5.84M 36.61% | 7.54M 29.10% | 12.24M 62.36% | 12.12M 1.01% | 5.28M 56.45% | |
average receivables | 625K - | 1.12M 78.88% | 20.60M 1,742.89% | 37.16M 80.38% | ||||||||
book value per share | -1.60 - | 20.70 1,390.72% | 12.32 40.49% | 8.83 28.30% | 5.96 32.56% | 7.73 29.86% | 5.67 26.73% | 6.25 10.28% | 2.99 52.24% | 1.24 58.40% | -0.94 175.46% | |
capex per share | -0.00 - | -0.01 2,013.14% | -0.01 22.86% | -0.11 827.25% | -0.68 544.56% | -0.82 21.03% | -0.11 86.37% | -0.06 45.40% | -0.11 85.14% | -0.04 63.60% | -0.01 71.91% | |
capex to depreciation | -0.75 - | -7.67 922.22% | -6.04 21.20% | -7.89 30.51% | -21.16 168.39% | -9.63 54.51% | -0.81 91.58% | -0.54 33.20% | -1.13 109.02% | -0.74 34.49% | -0.22 70.67% | |
capex to operating cash flow | 0.00 - | 0.00 450.15% | 0.01 182.13% | 0.05 544.62% | 0.23 359.56% | 0.20 13.57% | 0.02 87.82% | 0.02 2.61% | 0.05 92.16% | 0.02 67.68% | 0.01 59.13% | |
capex to revenue | -0.52 - | -0.07 87.32% | -0.14 116.29% | |||||||||
cash per share | 7.51 - | 20.88 177.99% | 12.53 40.01% | 8.90 28.96% | 5.56 37.50% | 7.07 27.07% | 5.05 28.54% | 6.77 34.02% | 3.96 41.47% | 2.38 39.90% | 0.49 79.49% | |
days of inventory on hand | 398.68 - | |||||||||||
days payables outstanding | 151.32 - | |||||||||||
days sales outstanding | 17.69 - | 230.93 1,205.13% | 1.45K 528.84% | |||||||||
debt to assets | 0.05 - | 0.03 44.25% | 0.06 136.37% | 0.19 215.42% | 0.28 44.93% | |||||||
debt to equity | 0.05 - | 0.03 39.87% | 0.10 211.10% | 0.57 460.00% | -0.46 181.33% | |||||||
dividend yield | ||||||||||||
earnings yield | -0.12 - | -0.21 75.15% | -0.08 59.67% | -0.19 128.77% | -0.22 14.10% | -0.15 31.43% | -0.34 127.17% | -0.21 38.68% | -0.23 9.12% | -0.68 196.19% | -5.08 644.96% | |
enterprise value | 21.56M - | 111.47M 417.04% | 651.90M 484.84% | 360.03M 44.77% | 461.30M 28.13% | 1.46B 216.78% | 784.86M 46.29% | 1.26B 61.14% | 1.40B 10.35% | 313.29M 77.55% | 74.16M 76.33% | |
enterprise value over ebitda | -2.50 - | -3.96 58.13% | -11.15 181.73% | -4.43 60.27% | -3.80 14.35% | -6.16 62.37% | -2.65 56.93% | -4.09 54.17% | -4.10 0.17% | -0.95 76.89% | -0.27 71.63% | |
ev to operating cash flow | -3.61 - | -6.70 85.51% | -17.54 161.73% | -6.00 65.81% | -5.27 12.11% | -8.13 54.19% | -3.33 59.02% | -7.00 110.05% | -6.33 9.54% | -1.16 81.70% | -0.38 66.83% | |
ev to sales | 68.62 - | 4.93 92.82% | 8.65 75.54% | |||||||||
free cash flow per share | -0.87 - | -3.34 284.97% | -1.46 56.24% | -2.19 49.91% | -3.61 64.41% | -4.92 36.47% | -4.70 4.45% | -2.50 46.76% | -2.47 1.49% | -2.69 9.14% | -1.83 31.90% | |
free cash flow yield | -0.08 - | -0.13 53.27% | -0.06 55.67% | -0.15 178.81% | -0.20 28.99% | -0.14 28.90% | -0.29 101.54% | -0.13 55.33% | -0.16 22.70% | -0.82 424.39% | -3.58 335.56% | |
graham net net | -1.63 - | 20.29 1,341.62% | 12.14 40.17% | 8.54 29.62% | 4.23 50.55% | 5.86 38.64% | 4.03 31.15% | 5.08 25.96% | 1.96 61.48% | 0.24 87.98% | -1.72 832.63% | |
graham number | 6.79 - | 51.15 653.55% | 24.90 51.32% | 23.38 6.09% | 23.16 0.96% | 30.27 30.73% | 26.89 11.17% | 24.14 10.22% | 15.62 35.32% | 7.91 49.36% | 7.41 6.25% | |
income quality | 0.68 - | 0.59 12.69% | 0.65 9.37% | 0.76 16.94% | 0.73 3.56% | 0.78 6.41% | 0.81 3.92% | 0.59 27.20% | 0.65 9.97% | 1.18 82.71% | 0.70 41.00% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -141.25 - | 52.22 136.97% | ||||||||||
interest debt per share | 0.31 - | 0.20 33.69% | 0.30 48.58% | 0.72 139.39% | 0.38 47.20% | |||||||
inventory turnover | 0.92 - | |||||||||||
invested capital | 0.05 - | 0.03 39.87% | 0.10 211.10% | 0.57 460.00% | -0.46 181.33% | |||||||
market cap | 73.17M - | 133.36M 82.26% | 675.65M 406.62% | 407.99M 39.61% | 540.52M 32.48% | 1.52B 181.58% | 845.04M 44.48% | 1.45B 71.84% | 1.48B 1.66% | 334.53M 77.34% | 54.31M 83.76% | |
net current asset value | -11.04M - | 103.09M 1,034.00% | 314.72M 205.30% | 250.38M 20.45% | 132.28M 47.17% | 268.51M 102.99% | 220.83M 17.76% | 397.49M 80.00% | 196.11M 50.66% | 45.30M 76.90% | -162.87M 459.53% | |
net debt to ebitda | 5.99 - | 0.78 87.03% | 0.41 47.76% | 0.59 45.33% | 0.65 10.41% | 0.26 60.73% | 0.20 20.49% | 0.61 197.86% | 0.24 60.97% | 0.06 72.86% | -0.07 212.01% | |
net income per share | -1.28 - | -5.62 339.94% | -2.24 60.18% | -2.75 23.01% | -4.00 45.44% | -5.27 31.60% | -5.67 7.70% | -4.15 26.91% | -3.63 12.39% | -2.24 38.36% | -2.61 16.47% | |
operating cash flow per share | -0.87 - | -3.34 284.10% | -1.45 56.45% | -2.09 43.84% | -2.93 40.25% | -4.10 40.04% | -4.59 11.92% | -2.44 46.79% | -2.35 3.66% | -2.65 12.63% | -1.82 31.28% | |
payables turnover | 2.41 - | |||||||||||
receivables turnover | 20.63 - | 1.58 92.34% | 0.25 84.10% | |||||||||
research and ddevelopement to revenue | 13.86 - | 4.29 69.08% | 26.22 511.63% | |||||||||
return on tangible assets | -0.17 - | -0.26 55.91% | -0.18 33.28% | -0.30 70.11% | -0.55 83.18% | -0.59 7.30% | -0.85 44.11% | -0.52 38.55% | -0.73 39.37% | -0.61 16.53% | -1.67 175.08% | |
revenue per share | 0.22 - | 0.62 187.05% | 0.08 87.01% | |||||||||
roe | 0.80 - | -0.27 134.08% | -0.18 33.09% | -0.31 71.56% | -0.67 115.64% | -0.68 1.34% | -1.00 46.98% | -0.66 33.73% | -1.22 83.43% | -1.80 48.20% | 2.78 254.36% | |
roic | 0.80 - | -0.27 134.19% | -0.19 31.97% | -0.32 72.66% | -0.68 113.35% | -0.70 2.40% | -0.92 31.82% | -0.63 31.66% | -1.02 62.05% | -1.09 7.12% | 35.18 3,315.92% | |
sales general and administrative to revenue | 3.87 - | 1.13 70.95% | 5.94 427.59% | |||||||||
shareholders equity per share | -1.60 - | 20.70 1,390.72% | 12.32 40.49% | 8.83 28.30% | 5.96 32.56% | 7.73 29.86% | 5.67 26.73% | 6.25 10.28% | 2.99 52.24% | 1.24 58.40% | -0.94 175.46% | |
stock based compensation to revenue | 2.65 - | 0.85 68.02% | 5.29 525.13% | |||||||||
tangible asset value | -11.02M - | 103.18M 1,036.57% | 315.10M 205.38% | 253.74M 19.47% | 177.86M 29.90% | 338.86M 90.51% | 290.78M 14.19% | 462.34M 59.00% | 279.61M 39.52% | 126.64M 54.71% | -99.23M 178.36% | |
tangible book value per share | -1.60 - | 20.70 1,390.72% | 12.32 40.49% | 8.83 28.30% | 5.96 32.56% | 7.73 29.86% | 5.67 26.73% | 6.25 10.28% | 2.99 52.24% | 1.24 58.40% | -0.94 175.46% | |
working capital | 50.28M - | 103.30M 105.44% | 314.89M 204.82% | 250.88M 20.33% | 144.54M 42.38% | 281.51M 94.76% | 236.25M 16.08% | 440.37M 86.40% | 278.83M 36.68% | 216.16M 22.48% | -40.36M 118.67% |
All numbers in (except ratios and percentages)